Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $8.53 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.85.
Market Cap
8.53T
Revenue
4.59T
Profits
199.01B
PE Ratio
42.85
Profit Margin
4.34%
Dividend Yield
0.42%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 988.20B | 0.55% | 1,887,986 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 572.08B | 2.75% | 4,911,216 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 412.21B | 1.43% | 3,723,476 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 370.41B | 0.30% | 3,521,000 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 293.39B | 2.87% | 4,602,775 | 65.77B |
| 6 | NVS | Novartis AG | 279.10B | 2.63% | 947,560 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 278.15B | 1.97% | 949,598 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 207.52B | 1.94% | 14,707,454 | 50.57B |
| 9 | AMGN | Amgen Inc. | 187.41B | 0.73% | 860,090 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 173.18B | 0.43% | 767,536 | 45.20B |
| 11 | ABT | Abbott Laboratories | 157.30B | 2.82% | 6,827,579 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 156.00B | 0.62% | 3,315,725 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 141.85B | -0.60% | 1,348,039 | 10.58B |
| 14 | PFE | Pfizer Inc. | 141.63B | -0.92% | 34,844,250 | 63.32B |
| 15 | CVS | CVS Health Corporation | 129.24B | -0.01% | 2,178,430 | 405.62B |
| 16 | DHR | Danaher Corporation | 126.19B | 0.06% | 1,558,998 | 24.78B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 119.23B | 0.64% | 543,686 | 12.22B |
| 18 | SYK | Stryker Corporation | 118.52B | 1.46% | 1,067,457 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 113.73B | 1.82% | 3,589,697 | 48.48B |
| 20 | MDT | Medtronic plc | 102.79B | 1.30% | 3,155,559 | 36.36B |
| 21 | GSK | GSK plc | 101.65B | 2.26% | 1,947,070 | 43.29B |
| 22 | SNY | Sanofi | 99.57B | -0.65% | 7,987,553 | 54.60B |
| 23 | MCK | McKesson Corporation | 89.45B | 2.58% | 621,377 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 85.84B | 0.12% | 358,462 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 85.84B | 2.64% | 588,151 | 76.39B |
| 26 | CI | The Cigna Group | 74.72B | 0.13% | 459,600 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 67.26B | 2.08% | 9,453,738 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.90B | 0.95% | 404,453 | 14.92B |
| 29 | ARGX | argenx SE | 56.65B | -2.42% | 257,054 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.42B | 3.11% | 934,171 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 53.13B | 1.85% | 645,553 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 49.67B | 0.44% | 1,788,862 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.05B | 2.17% | 1,797,934 | 28.34B |
| 34 | MDLN | Medline Inc. | 46.44B | 1.84% | 2,625,512 | 29.14B |
| 35 | HUM | Humana Inc. | 43.52B | 0.48% | 689,985 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 42.63B | -0.97% | 308,308 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 39.91B | 2.94% | 1,396,550 | 22.23B |
| 38 | HLN | Haleon plc | 38.75B | 1.88% | 6,788,630 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.64B | 1.04% | 536,290 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 38.33B | 2.24% | 2,501,472 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 35.88B | 0.43% | 564,616 | 7.23B |
| 42 | RVMD | Revolution Medicines, Inc. | 35.75B | 1.42% | 1,905,318 | - |
| 43 | WAT | Waters Corporation | 35.05B | -0.35% | 403,216 | 3.77B |
| 44 | NTRA | Natera, Inc. | 34.03B | 3.85% | 983,110 | 2.50B |
| 45 | ALC | Alcon Inc. | 32.10B | 0.84% | 1,569,442 | 10.63B |
| 46 | ZTS | Zoetis Inc. | 32.09B | 0.86% | 2,695,395 | 9.53B |
| 47 | CNC | Centene Corporation | 31.54B | 0.30% | 1,873,533 | 178.33B |
| 48 | RPRX | Royalty Pharma plc | 31.43B | 1.89% | 2,119,787 | 2.44B |
| 49 | ONC | BeOne Medicines AG | 30.59B | 1.24% | 200,527 | 5.70B |
| 50 | BIIB | Biogen Inc. | 29.56B | 0.26% | 362,129 | 9.94B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 28.96B | 4.98% | 4,033,855 | 20.98B |
| 52 | IQV | IQVIA Holdings Inc. | 28.68B | 2.38% | 728,570 | 16.63B |
| 53 | RMD | ResMed Inc. | 27.51B | 1.09% | 605,845 | 5.54B |
| 54 | DXCM | DexCom, Inc. | 26.59B | -0.23% | 3,164,218 | 4.82B |
| 55 | PHG | Koninklijke Philips N.V. | 25.80B | -1.39% | 541,350 | 20.34B |
| 56 | VEEV | Veeva Systems Inc. | 25.78B | 3.63% | 1,887,093 | 3.32B |
| 57 | ILMN | Illumina, Inc. | 24.84B | 1.73% | 812,013 | 4.39B |
| 58 | MRNA | Moderna, Inc. | 24.48B | 3.97% | 4,446,927 | 2.23B |
| 59 | WST | West Pharmaceutical Services, Inc. | 23.60B | 1.30% | 295,892 | 3.22B |
| 60 | MTD | Mettler-Toledo International Inc. | 23.21B | -1.31% | 136,531 | 4.09B |
| 61 | UTHR | United Therapeutics Corporation | 23.18B | 1.45% | 165,477 | 3.17B |
| 62 | BNTX | BioNTech SE | 22.95B | 0.62% | 209,746 | 3.23B |
| 63 | ROIV | Roivant Sciences Ltd. | 22.67B | 0.86% | 2,320,567 | 8.26M |
| 64 | INSM | Insmed Incorporated | 22.08B | 3.29% | 2,859,536 | 819.56M |
| 65 | DGX | Quest Diagnostics Incorporated | 21.81B | 1.77% | 400,212 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 21.21B | 1.67% | 173,466 | 14.14B |
| 67 | INCY | Incyte Corporation | 20.96B | 1.21% | 584,835 | 5.36B |
| 68 | STE | STERIS plc | 19.69B | 0.80% | 316,984 | 5.94B |
| 69 | VTRS | Viatris Inc. | 18.27B | 1.98% | 3,447,743 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.63B | 3.20% | 1,242,628 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.96B | 0.69% | 626,089 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.30B | 0.31% | 420,613 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.97B | 1.52% | 854,906 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.51B | 0.72% | 261,077 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 14.55B | 2.78% | 459,555 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.29B | 0.82% | 416,887 | 4.44B |
| 77 | BTSG | BrightSpring Health Services, Inc. | 14.06B | 0.43% | 1,024,235 | 13.65B |
| 78 | DVA | DaVita Inc. | 13.56B | 0.76% | 288,701 | 13.84B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.49B | -0.09% | 1,210,495 | 579.96M |
| 80 | MEDP | Medpace Holdings, Inc. | 13.30B | 2.18% | 138,091 | 2.68B |
| 81 | EXEL | Exelixis, Inc. | 12.96B | 0.45% | 1,371,702 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 12.87B | 0.89% | 1,222,784 | 4.23B |
| 83 | SOLV | Solventum Corporation | 12.76B | 0.14% | 569,570 | 8.26B |
| 84 | AXSM | Axsome Therapeutics, Inc. | 12.70B | -0.39% | 446,284 | 708.24M |
| 85 | FMS | Fresenius Medical Care AG | 12.70B | 1.28% | 304,199 | 22.32B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.65B | 0.86% | 645,402 | 1.06B |
| 87 | SNN | Smith & Nephew plc | 12.52B | 0.77% | 691,462 | 6.16B |
| 88 | PEN | Penumbra, Inc. | 12.49B | 0.41% | 116,194 | 1.45B |
| 89 | ALGN | Align Technology, Inc. | 12.30B | -1.15% | 407,451 | 4.10B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.86B | 0.33% | 139,787 | 1.13B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.59B | -2.93% | 2,095,121 | 4.89B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.47B | 1.55% | 2,339,332 | 3.58B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.31B | -2.05% | 691,919 | 622.01M |
| 94 | SMMT | Summit Therapeutics Inc. | 11.23B | 1.33% | 3,787,105 | - |
| 95 | RVTY | Revvity, Inc. | 11.15B | 0.94% | 565,350 | 2.90B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.96B | 1.45% | 797,024 | 3.24B |
| 97 | ICLR | ICON Public Limited Company | 10.96B | 1.72% | 300,677 | 8.25B |
| 98 | GMED | Globus Medical, Inc. | 10.81B | 0.61% | 728,337 | 3.10B |
| 99 | CYTK | Cytokinetics, Incorporated | 10.74B | -0.05% | 972,384 | 105.82M |
| 100 | BAX | Baxter International Inc. | 10.35B | 1.91% | 2,365,609 | 11.32B |
| 101 | MOH | Molina Healthcare, Inc. | 10.21B | -0.74% | 414,769 | 43.10B |
| 102 | KRYS | Krystal Biotech, Inc. | 10.05B | -0.71% | 134,979 | 417.30M |
| 103 | PODD | Insulet Corporation | 10.00B | 3.87% | 715,054 | 2.90B |
| 104 | APGE | Apogee Therapeutics, Inc. | 9.96B | 0.24% | 7,036,384 | - |
| 105 | EHC | Encompass Health Corporation | 9.91B | 1.28% | 631,531 | 6.07B |
| 106 | NUVL | Nuvalent, Inc. | 9.75B | 0.01% | 964,679 | - |
| 107 | ENSG | The Ensign Group, Inc. | 9.30B | 2.39% | 435,636 | 5.27B |
| 108 | HSIC | Henry Schein, Inc. | 9.14B | 1.94% | 510,758 | 13.38B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.99B | 2.81% | 266,964 | 4.03B |
| 110 | UHS | Universal Health Services, Inc. | 8.86B | 2.55% | 371,515 | 17.76B |
| 111 | TECH | Bio-Techne Corporation | 8.81B | 1.20% | 770,780 | 1.21B |
| 112 | TEM | Tempus AI, Inc. | 8.76B | 1.90% | 3,711,054 | 1.36B |
| 113 | OSCR | Oscar Health, Inc. | 8.76B | 1.86% | 3,614,558 | 13.30B |
| 114 | CORT | Corcept Therapeutics Incorporated | 8.62B | 0.73% | 512,579 | 769.10M |
| 115 | SYRE | Spyre Therapeutics, Inc. | 8.47B | -2.76% | 1,517,101 | - |
| 116 | BRKR | Bruker Corporation | 8.47B | -1.57% | 1,209,416 | 3.46B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 8.42B | -0.42% | 193,306 | 7.46M |
| 118 | HALO | Halozyme Therapeutics, Inc. | 8.28B | 1.13% | 529,638 | 1.51B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.07B | -1.40% | 1,041,127 | 51.48M |
| 120 | ALKS | Alkermes plc | 8.02B | 4.61% | 1,185,378 | 1.56B |
| 121 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 7.83B | -3.49% | 1,193,866 | 5.67M |
| 122 | GKOS | Glaukos Corporation | 7.82B | 1.49% | 173,540 | 551.35M |
| 123 | ATR | AptarGroup, Inc. | 7.78B | 1.55% | 161,363 | 3.87B |
| 124 | QGEN | Qiagen N.V. | 7.74B | 3.14% | 1,000,782 | 2.10B |
| 125 | IBRX | ImmunityBio, Inc. | 7.73B | 2.22% | 8,188,623 | 140.98M |
| 126 | IMVT | Immunovant, Inc. | 7.71B | -1.39% | 424,607 | - |
| 127 | HIMS | Hims & Hers Health, Inc. | 7.66B | -1.28% | 8,824,487 | 2.37B |
| 128 | TGTX | TG Therapeutics, Inc. | 7.62B | -1.19% | 1,306,218 | 700.35M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 7.60B | 2.71% | 289,304 | 74.06M |
| 130 | PCVX | Vaxcyte, Inc. | 7.57B | 0.57% | 544,653 | - |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 7.33B | -2.50% | 342,822 | 2.59B |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.21B | 3.80% | 803,582 | 217.17M |
| 133 | HQY | HealthEquity, Inc. | 7.17B | 1.41% | 377,687 | 1.34B |
| 134 | RGEN | Repligen Corporation | 7.08B | -0.83% | 541,296 | 763.34M |
| 135 | LNTH | Lantheus Holdings, Inc. | 6.94B | 0.42% | 341,121 | 1.55B |
| 136 | PTCT | PTC Therapeutics, Inc. | 6.83B | 1.71% | 1,654,802 | 827.11M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 6.67B | 1.43% | 518,911 | 569.61M |
| 138 | LQDA | Liquidia Corporation | 6.62B | -1.40% | 819,669 | 288.07M |
| 139 | GRFS | Grifols, S.A. | 6.28B | -1.17% | 464,622 | 8.58B |
| 140 | AVTR | Avantor, Inc. | 6.26B | -1.93% | 6,277,855 | 6.55B |
| 141 | CNTA | Centessa Pharmaceuticals plc | 6.26B | 0.66% | 8,350,100 | 15.00M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.25B | 2.01% | 2,862,314 | - |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.12B | 3.82% | 1,293,081 | - |
| 144 | PACS | PACS Group, Inc. | 5.96B | -0.24% | 418,844 | 5.43B |
| 145 | CHE | Chemed Corporation | 5.87B | 1.77% | 128,434 | 2.54B |
| 146 | CGON | CG Oncology, Inc. | 5.82B | -0.41% | 349,572 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 5.78B | -0.03% | 148,961 | - |
| 148 | RGC | Regencell Bioscience Holdings Limited | 5.57B | 7.04% | 193,099 | - |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 5.55B | 5.69% | 1,820,767 | 274.48M |
| 150 | TFX | Teleflex Incorporated | 5.51B | 2.29% | 193,438 | 2.13B |
| 151 | LEGN | Legend Biotech Corporation | 5.49B | 0.78% | 1,412,769 | 1.14B |
| 152 | BLCO | Bausch + Lomb Corporation | 5.42B | 1.74% | 164,175 | 5.21B |
| 153 | HNGE | Hinge Health, Inc. | 5.39B | 1.22% | 408,811 | 646.34M |
| 154 | TWST | Twist Bioscience Corporation | 5.36B | 1.08% | 987,356 | 409.48M |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 5.28B | -0.26% | 769,359 | 7.50M |
| 156 | AMRX | Amneal Pharmaceuticals, Inc. | 5.27B | 2.48% | 705,979 | 3.05B |
| 157 | CRSP | CRISPR Therapeutics AG | 5.23B | -0.20% | 867,075 | 4.10M |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.16B | 0.71% | 864,222 | 536.20M |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.14B | -0.14% | 821,952 | - |
| 160 | CAI | Caris Life Sciences, Inc. | 5.00B | 2.14% | 1,637,264 | 907.29M |
| 161 | INDV | Indivior PLC | 4.94B | 3.21% | 748,599 | 1.18B |
| 162 | DNTH | Dianthus Therapeutics, Inc. | 4.80B | 0.57% | 564,836 | 1.34M |
| 163 | BLLN | BillionToOne, Inc. | 4.79B | 3.46% | 310,203 | 354.54M |
| 164 | ERAS | Erasca, Inc. | 4.66B | -0.73% | 2,812,701 | - |
| 165 | STVN | Stevanato Group S.p.A. | 4.64B | 0.27% | 159,206 | 1.39B |
| 166 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.58B | 4.19% | 487,804 | 754.05M |
| 167 | ALHC | Alignment Healthcare, Inc. | 4.50B | 2.16% | 1,116,454 | 4.26B |
| 168 | SHC | Sotera Health Company | 4.48B | -0.10% | 1,013,798 | 1.19B |
| 169 | CELC | Celcuity Inc. | 4.43B | 0.98% | 366,771 | - |
| 170 | RDNT | RadNet, Inc. | 4.39B | 0.07% | 274,012 | 2.14B |
| 171 | LIVN | LivaNova PLC | 4.35B | 0.58% | 283,685 | 1.43B |
| 172 | MANE | Veradermics, Incorporated | 4.32B | 0.52% | 413,098 | - |
| 173 | VCYT | Veracyte, Inc. | 4.26B | 0.39% | 412,790 | 541.74M |
| 174 | TNGX | Tango Therapeutics, Inc. | 4.16B | 0.81% | 3,099,688 | 56.99M |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.15B | 5.67% | 557,805 | - |
| 176 | NVST | Envista Holdings Corporation | 4.14B | -0.20% | 622,256 | 2.81B |
| 177 | TXG | 10x Genomics, Inc. | 4.08B | -2.49% | 1,786,798 | 638.78M |
| 178 | VKTX | Viking Therapeutics, Inc. | 4.05B | 7.85% | 4,468,724 | - |
| 179 | MMSI | Merit Medical Systems, Inc. | 4.01B | 0.96% | 325,687 | 1.54B |
| 180 | DFTX | Definium Therapeutics, Inc. | 3.99B | -0.35% | 4,306,550 | - |
| 181 | DNLI | Denali Therapeutics Inc. | 3.95B | 3.58% | 788,375 | - |
| 182 | MMED | MiniMed Group, Inc. | 3.95B | -1.20% | 253,300 | 3.10B |
| 183 | ACAD | ACADIA Pharmaceuticals Inc. | 3.86B | 2.04% | 639,392 | 1.10B |
| 184 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.85B | 3.22% | 525,350 | 18.07M |
| 185 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.02% | 553,658 | 596.96M |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.80B | 0.78% | 1,520,781 | 10.68M |
| 187 | DOCS | Doximity, Inc. | 3.79B | 3.29% | 1,436,542 | 644.86M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.68B | 1.02% | 186,934 | 2.23B |
| 189 | LFST | LifeStance Health Group, Inc. | 3.66B | 2.61% | 1,418,144 | 1.49B |
| 190 | NAMS | NewAmsterdam Pharma Company N.V. | 3.64B | 1.01% | 593,430 | 22.57M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.63B | 5.47% | 540,274 | 787.85M |
| 192 | WAY | Waystar Holding Corp. | 3.56B | 7.28% | 2,165,243 | 1.16B |
| 193 | OGN | Organon & Co. | 3.53B | 0.34% | 737,239 | 6.16B |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.50B | 2.28% | 844,283 | 236.00M |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.48B | -0.69% | 329,912 | - |
| 196 | TLX | Telix Pharmaceuticals Limited | 3.46B | 2.30% | 205,363 | 803.79M |
| 197 | OPCH | Option Care Health, Inc. | 3.46B | 3.38% | 1,214,538 | 5.67B |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.42B | -0.96% | 1,223,998 | - |
| 199 | ICUI | ICU Medical, Inc. | 3.40B | -0.10% | 97,528 | 2.16B |
| 200 | BEAM | Beam Therapeutics Inc. | 3.37B | -4.78% | 2,393,281 | 164.01M |
| 201 | HAE | Haemonetics Corporation | 3.33B | 1.12% | 197,768 | 1.33B |
| 202 | BKD | Brookdale Senior Living Inc. | 3.31B | -0.96% | 1,716,782 | 3.00B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | -0.96% | 667,297 | 415.62M |
| 204 | GPCR | Structure Therapeutics Inc. | 3.19B | -1.23% | 678,684 | - |
| 205 | WRBY | Warby Parker Inc. | 3.18B | -3.85% | 1,272,115 | 890.57M |
| 206 | NHC | National HealthCare Corporation | 3.16B | 0.49% | 79,870 | 1.53B |
| 207 | ALMS | Alumis Inc. | 3.12B | -0.61% | 758,591 | 8.40M |
| 208 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | 2.42% | 1,237,905 | 225.27M |
| 209 | QURE | uniQure N.V. | 3.03B | 8.13% | 1,877,310 | 18.09M |
| 210 | ITGR | Integer Holdings Corporation | 3.00B | -1.80% | 113,840 | 1.86B |
| 211 | PRVA | Privia Health Group, Inc. | 3.00B | 1.32% | 299,502 | 2.25B |
| 212 | HTFL | HeartFlow, Inc. | 2.95B | 1.06% | 675,267 | 191.42M |
| 213 | ELVN | Enliven Therapeutics, Inc. | 2.93B | 4.68% | 1,379,674 | - |
| 214 | RARE | Ultragenyx Pharmaceutical Inc. | 2.86B | 0.45% | 845,704 | 670.00M |
| 215 | KLRA | Kailera Therapeutics, Inc. | 2.83B | -4.37% | 256,322 | - |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 2.81B | 2.91% | 824,585 | 535.08M |
| 217 | ADPT | Adaptive Biotechnologies Corporation | 2.81B | 0.98% | 1,307,542 | 295.41M |
| 218 | IRON | Disc Medicine, Inc. | 2.72B | 0.40% | 349,070 | - |
| 219 | VERA | Vera Therapeutics, Inc. | 2.71B | -1.90% | 814,220 | - |
| 220 | GRAL | GRAIL, Inc. | 2.66B | -0.02% | 202,088 | 156.12M |
| 221 | CLOV | Clover Health Investments, Corp. | 2.66B | -1.75% | 6,109,389 | 2.21B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.62B | -0.03% | 353,390 | 865.00K |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.59B | 0.51% | 311,798 | 776.83M |
| 224 | TMDX | TransMedics Group, Inc. | 2.58B | -1.26% | 534,649 | 635.89M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.54B | 0.26% | 211,721 | 229.58M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | -5.20% | 258,302 | 1.46B |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.51B | -0.11% | 1,869,310 | - |
| 228 | AXGN | Axogen, Inc. | 2.40B | 0.44% | 672,192 | 238.11M |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.40B | 3.17% | 2,978,490 | 885.72M |
| 230 | KOD | Kodiak Sciences Inc. | 2.38B | 4.20% | 213,505 | - |
| 231 | PHVS | Pharvaris N.V. | 2.33B | 1.03% | 130,990 | - |
| 232 | OCUL | Ocular Therapeutix, Inc. | 2.28B | 4.61% | 1,726,221 | 52.04M |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.28B | 1.23% | 1,485,149 | 298.30M |
| 234 | BHVN | Biohaven Ltd. | 2.28B | -2.35% | 1,391,851 | - |
| 235 | NKTR | Nektar Therapeutics | 2.27B | 2.48% | 494,662 | 55.63M |
| 236 | ACHC | Acadia Healthcare Company, Inc. | 2.20B | -5.16% | 1,360,613 | 3.37B |
| 237 | PBH | Prestige Consumer Healthcare Inc. | 2.19B | 1.63% | 247,688 | 1.09B |
| 238 | MBX | MBX Biosciences, Inc. | 2.18B | 4.21% | 402,738 | - |
| 239 | IMNM | Immunome, Inc. | 2.17B | - | 254,334 | 4.02M |
| 240 | NTLA | Intellia Therapeutics, Inc. | 2.13B | -3.43% | 3,136,715 | 66.09M |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.12B | 1.51% | 434,521 | 66.05M |
| 242 | MLYS | Mineralys Therapeutics, Inc. | 2.10B | 0.55% | 918,607 | - |
| 243 | LMAT | LeMaitre Vascular, Inc. | 2.10B | 3.66% | 234,081 | 256.28M |
| 244 | ZLAB | Zai Lab Limited | 2.09B | 0.43% | 1,134,007 | 453.28M |
| 245 | NUVB | Nuvation Bio Inc. | 2.08B | 3.82% | 3,018,063 | 143.05M |
| 246 | PGNY | Progyny, Inc. | 2.08B | 1.07% | 464,438 | 1.29B |
| 247 | VCEL | Vericel Corporation | 2.07B | 0.04% | 215,310 | 292.09M |
| 248 | SEM | Select Medical Holdings Corporation | 2.05B | - | 223,470 | 5.52B |
| 249 | XRAY | DENTSPLY SIRONA Inc. | 2.02B | -0.44% | 2,250,249 | 3.68B |
| 250 | ASTH | Astrana Health, Inc. | 2.02B | 3.08% | 268,923 | 3.53B |
| 251 | ADMA | ADMA Biologics, Inc. | 2.01B | 1.34% | 1,449,589 | 509.86M |
| 252 | BFLY | Butterfly Network, Inc. | 2.00B | 5.23% | 10,047,160 | 102.92M |
| 253 | IOVA | Iovance Biotherapeutics, Inc. | 1.99B | 9.98% | 12,545,369 | 285.61M |
| 254 | TSHA | Taysha Gene Therapies, Inc. | 1.99B | 5.82% | 1,133,222 | 7.47M |
| 255 | GENB | Generate Biomedicines, Inc. | 1.98B | -2.58% | 418,420 | 30.30M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | 2.18% | 166,118 | 899.11M |
| 257 | KARD | Kardigan, Inc. | 1.97B | -2.94% | 295,595 | - |
| 258 | MESO | Mesoblast Limited | 1.97B | -0.65% | 90,425 | 65.38M |
| 259 | STOK | Stoke Therapeutics, Inc. | 1.97B | 2.03% | 882,943 | 32.08M |
| 260 | NRIX | Nurix Therapeutics, Inc. | 1.97B | 1.93% | 359,148 | 71.78M |
| 261 | VRDN | Viridian Therapeutics, Inc. | 1.93B | -0.79% | 1,010,519 | 70.92M |
| 262 | NEOG | Neogen Corporation | 1.92B | -1.07% | 419,821 | 870.56M |
| 263 | MD | Pediatrix Medical Group, Inc. | 1.92B | 1.65% | 221,698 | 1.93B |
| 264 | PGEN | Precigen, Inc. | 1.90B | -0.74% | 3,493,003 | 31.60M |
| 265 | SGRY | Surgery Partners, Inc. | 1.89B | 0.34% | 264,133 | 3.34B |
| 266 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.24% | 105,539 | 1.20B |
| 267 | RAPP | Rapport Therapeutics, Inc. | 1.87B | 2.33% | 95,841 | 20.00M |
| 268 | SRPT | Sarepta Therapeutics, Inc. | 1.84B | -1.19% | 1,238,350 | 2.18B |
| 269 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.84B | 1.54% | 1,119,011 | -665.00K |
| 270 | UFPT | UFP Technologies, Inc. | 1.83B | 1.18% | 127,732 | 608.85M |
| 271 | AGL | agilon health, inc. | 1.82B | -3.78% | 218,526 | 5.82B |
| 272 | TYRA | Tyra Biosciences, Inc. | 1.81B | 0.96% | 445,218 | - |
| 273 | PLSE | Pulse Biosciences, Inc. | 1.81B | 1.67% | 73,036 | 751.00K |
| 274 | NBTX | Nanobiotix S.A. | 1.80B | 3.09% | 109,711 | 38.27M |
| 275 | WGS | GeneDx Holdings Corp. | 1.79B | 9.00% | 568,508 | 442.68M |
| 276 | SION | Sionna Therapeutics, Inc. | 1.79B | 2.27% | 323,463 | - |
| 277 | HCM | HUTCHMED (China) Limited | 1.78B | 1.30% | 8,516 | 548.51M |
| 278 | BHC | Bausch Health Companies Inc. | 1.78B | 1.93% | 736,005 | 10.53B |
| 279 | AVAH | Aveanna Healthcare Holdings Inc. | 1.76B | 2.15% | 1,381,377 | 2.52B |
| 280 | ZYME | Zymeworks Inc. | 1.76B | 3.61% | 382,346 | 81.26M |
| 281 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | 2.76% | 189,197 | 923.71M |
| 282 | ADUS | Addus HomeCare Corporation | 1.75B | 0.65% | 135,412 | 1.45B |
| 283 | ABCL | AbCellera Biologics Inc. | 1.74B | -0.61% | 4,071,812 | 79.21M |
| 284 | OMCL | Omnicell, Inc. | 1.74B | -1.01% | 166,726 | 1.23B |
| 285 | ANAB | AnaptysBio, Inc. | 1.74B | -0.43% | 236,655 | 232.39M |
| 286 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | 1.50% | 539,913 | 217.17M |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.73B | 9.48% | 827,985 | 42.95M |
| 288 | INVA | Innoviva, Inc. | 1.72B | 2.78% | 239,851 | 420.69M |
| 289 | CMPS | COMPASS Pathways plc | 1.72B | 0.63% | 1,657,384 | - |
| 290 | URGN | UroGen Pharma Ltd. | 1.71B | 0.11% | 305,634 | 140.49M |
| 291 | CAPR | Capricor Therapeutics, Inc. | 1.71B | 0.44% | 350,056 | 11.13M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.70B | -0.14% | 187,545 | 367.34M |
| 293 | VIR | Vir Biotechnology, Inc. | 1.70B | 5.54% | 1,287,038 | 65.50M |
| 294 | PVLA | Palvella Therapeutics, Inc. | 1.69B | -0.66% | 110,313 | - |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | -0.31% | 7,569,774 | 66.41M |
| 296 | SLS | SELLAS Life Sciences Group, Inc. | 1.68B | 5.98% | 5,281,208 | - |
| 297 | SEPN | Septerna, Inc. | 1.66B | 5.94% | 168,662 | 72.26M |
| 298 | BCAX | Bicara Therapeutics Inc. | 1.65B | 2.08% | 403,833 | - |
| 299 | GHRS | GH Research PLC | 1.63B | 7.63% | 209,822 | - |
| 300 | NVCR | NovoCure Limited | 1.62B | 2.79% | 865,006 | 674.41M |
| 301 | TRLV | Trulieve Cannabis Corp. | 1.61B | -8.22% | 1,699,346 | 1.17B |
| 302 | ALMR | Alamar Biosciences, Inc. | 1.61B | 1.67% | 73,642 | 87.16M |
| 303 | HROW | Harrow, Inc. | 1.60B | 1.39% | 560,315 | 268.68M |
| 304 | MLTX | MoonLake Immunotherapeutics | 1.60B | -2.21% | 1,227,641 | - |
| 305 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 3.36% | 578,147 | - |
| 306 | HCSG | Healthcare Services Group, Inc. | 1.57B | 1.18% | 289,765 | 1.85B |
| 307 | ARDX | Ardelyx, Inc. | 1.54B | -2.12% | 1,561,969 | 427.68M |
| 308 | FTRE | Fortrea Holdings Inc. | 1.54B | 4.31% | 620,514 | 2.71B |
| 309 | ATAI | AtaiBeckley Inc. | 1.52B | 1.85% | 2,830,226 | 3.49M |
| 310 | DMRA | Damora Therapeutics, Inc. | 1.51B | 2.41% | 167,887 | - |
| 311 | NVAX | Novavax, Inc. | 1.50B | 1.44% | 2,999,308 | 596.34M |
| 312 | NEO | NeoGenomics, Inc. | 1.49B | 2.41% | 998,788 | 745.97M |
| 313 | IMCR | Immunocore Holdings plc | 1.49B | -0.10% | 323,373 | 412.81M |
| 314 | AKTS | Aktis Oncology, Inc. | 1.49B | 8.49% | 268,064 | 8.28M |
| 315 | AAPG | Ascentage Pharma Group International | 1.48B | -0.29% | 13,525 | 82.08M |
| 316 | SVRA | Savara Inc. | 1.47B | 2.02% | 1,029,536 | - |
| 317 | ATRC | AtriCure, Inc. | 1.44B | 0.25% | 395,398 | 552.16M |
| 318 | MAZE | Maze Therapeutics, Inc. | 1.44B | 1.96% | 284,520 | 20.00M |
| 319 | TDOC | Teladoc Health, Inc. | 1.39B | 1.85% | 2,254,561 | 2.51B |
| 320 | STAA | STAAR Surgical Company | 1.39B | -3.33% | 234,413 | 290.38M |
| 321 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 1.31% | 409,887 | 1.64B |
| 322 | IMTX | Immatics N.V. | 1.38B | 3.12% | 162,685 | 43.00M |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.37B | 1.43% | 582,572 | 204.73M |
| 324 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -0.10% | 209,860 | 1.30M |
| 325 | MPLT | MapLight Therapeutics, Inc. | 1.34B | -0.57% | 191,080 | - |
| 326 | AVLN | Avalyn Pharma Inc. | 1.34B | -2.87% | 129,752 | - |
| 327 | ARDT | Ardent Health, Inc. | 1.32B | 1.77% | 147,440 | 6.43B |
| 328 | PRGO | Perrigo Company plc | 1.32B | -0.83% | 1,655,552 | 4.18B |
| 329 | ATEC | Alphatec Holdings, Inc. | 1.32B | 0.06% | 1,060,297 | 787.08M |
| 330 | CDNA | CareDx, Inc. | 1.30B | 0.76% | 241,261 | 412.82M |
| 331 | ZBIO | Zenas BioPharma, Inc. | 1.30B | -0.82% | 274,142 | 10.00M |
| 332 | AHCO | AdaptHealth Corp. | 1.29B | 0.62% | 978,329 | 3.29B |
| 333 | COAG | Hemab Therapeutics Holdings, Inc. | 1.29B | -8.29% | 65,585 | - |
| 334 | INNV | InnovAge Holding Corp. | 1.28B | 2.39% | 148,269 | 949.17M |
| 335 | JBIO | Jade Biosciences, Inc. | 1.26B | 8.84% | 561,935 | - |
| 336 | PAHC | Phibro Animal Health Corporation | 1.25B | -0.80% | 88,902 | 1.50B |
| 337 | XERS | Xeris Biopharma Holdings, Inc. | 1.24B | 4.20% | 1,176,963 | 314.85M |
| 338 | ALVO | Alvotech | 1.24B | 1.23% | 497,509 | 562.04M |
| 339 | BLFS | BioLife Solutions, Inc. | 1.23B | 1.16% | 331,356 | 101.66M |
| 340 | ENOV | Enovis Corporation | 1.22B | -0.38% | 359,559 | 2.28B |
| 341 | EYPT | EyePoint, Inc. | 1.22B | 5.75% | 787,723 | 7.61M |
| 342 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 0.29% | 114,413 | 83.72M |
| 343 | ABSI | Absci Corporation | 1.21B | -7.50% | 3,713,936 | 1.84M |
| 344 | MNKD | MannKind Corporation | 1.20B | 0.26% | 1,342,026 | 360.78M |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.20B | 2.27% | 292,995 | 3.42B |
| 346 | AHG | Akso Health Group | 1.20B | 4.10% | 13,493 | 14.84M |
| 347 | INSP | Inspire Medical Systems, Inc. | 1.19B | 0.29% | 429,089 | 915.25M |
| 348 | PNTG | The Pennant Group, Inc. | 1.18B | 0.77% | 103,323 | 1.02B |
| 349 | WVE | Wave Life Sciences Ltd. | 1.18B | -0.81% | 1,320,594 | 71.80M |
| 350 | IRMD | IRADIMED CORPORATION | 1.17B | 0.07% | 110,021 | 86.28M |
| 351 | AVNS | Avanos Medical, Inc. | 1.17B | 0.10% | 182,208 | 715.90M |
| 352 | PRCT | PROCEPT BioRobotics Corporation | 1.14B | -4.56% | 929,897 | 322.02M |
| 353 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | 3.83% | 109,301 | 796.33M |
| 354 | SDGR | Schrรถdinger, Inc. | 1.12B | -1.18% | 473,712 | 254.91M |
| 355 | OPK | OPKO Health, Inc. | 1.11B | 2.45% | 1,638,506 | 581.12M |
| 356 | OMDA | Omada Health, Inc. | 1.10B | 2.61% | 614,364 | 283.30M |
| 357 | MGTX | MeiraGTx Holdings plc | 1.09B | 2.35% | 442,547 | 79.76M |
| 358 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 2.14% | 1,191,225 | - |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.07B | 1.51% | 567,161 | - |
| 360 | XNCR | Xencor, Inc. | 1.07B | 2.64% | 456,308 | 97.36M |
| 361 | PSNL | Personalis, Inc. | 1.06B | -0.79% | 1,197,668 | 64.52M |
| 362 | NUTX | Nutex Health Inc. | 1.03B | -0.05% | 50,638 | 879.95M |
| 363 | SPRY | ARS Pharmaceuticals, Inc. | 1.02B | 2.96% | 849,696 | 98.99M |
| 364 | AZTA | Azenta, Inc. | 1.02B | -0.76% | 217,886 | 596.48M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.01B | 4.78% | 123,519 | - |
| 366 | CNMD | CONMED Corporation | 1.01B | 2.74% | 348,664 | 1.37B |
| 367 | AVR | Anteris Technologies Global Corp. | 1.01B | 7.72% | 691,516 | 1.85M |
| 368 | SANA | Sana Biotechnology, Inc. | 1.00B | -0.30% | 1,762,889 | - |
| 369 | CRON | Cronos Group Inc. | 989.41M | 0.94% | 499,152 | 159.54M |
| 370 | AORT | Artivion, Inc. | 988.34M | 1.14% | 228,809 | 458.69M |
| 371 | BIOA | BioAge Labs, Inc. | 986.85M | 3.40% | 223,625 | 10.32M |
| 372 | TNDM | Tandem Diabetes Care, Inc. | 976.54M | -0.63% | 1,655,639 | 1.03B |
| 373 | USPH | U.S. Physical Therapy, Inc. | 972.78M | 2.26% | 63,735 | 787.69M |
| 374 | DBVT | DBV Technologies S.A. | 968.08M | 2.55% | 208,989 | 5.74M |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 963.91M | 0.93% | 2,074,383 | 69.64M |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 953.83M | 9.20% | 1,470,164 | - |
| 377 | AVTX | Avalo Therapeutics, Inc. | 953.54M | 6.21% | 1,363,880 | 59.00K |
| 378 | EVO | Evotec SE | 949.98M | 0.76% | 14,522 | 859.03M |
| 379 | REPL | Replimune Group, Inc. | 940.50M | 1.88% | 1,975,583 | - |
| 380 | ORIC | ORIC Pharmaceuticals, Inc. | 938.90M | 1.57% | 639,631 | - |
| 381 | PHAR | Pharming Group N.V. | 931.75M | 1.01% | 5,945 | 369.49M |
| 382 | KURA | Kura Oncology, Inc. | 928.14M | 0.92% | 670,450 | 71.64M |
| 383 | PCRX | Pacira BioSciences, Inc. | 923.10M | 3.30% | 135,101 | 734.86M |
| 384 | ETON | Eton Pharmaceuticals, Inc. | 920.38M | 2.69% | 219,262 | 86.93M |
| 385 | LMRI | Lumexa Imaging Holdings, Inc. | 917.57M | 0.63% | 116,911 | 1.03B |
| 386 | JANX | Janux Therapeutics, Inc. | 908.67M | 3.91% | 810,005 | 13.73M |
| 387 | ANRO | Alto Neuroscience, Inc. | 899.81M | 11.82% | 204,663 | - |
| 388 | DRTS | Alpha Tau Medical Ltd. | 898.15M | -0.70% | 438,541 | - |
| 389 | GDRX | GoodRx Holdings, Inc. | 894.10M | 2.72% | 298,944 | 787.89M |
| 390 | ODTX | Odyssey Therapeutics, Inc. | 878.15M | -0.56% | 163,601 | 1.06M |
| 391 | ANNX | Annexon, Inc. | 876.56M | 6.15% | 3,700,240 | - |
| 392 | TBPH | Theravance Biopharma, Inc. | 873.82M | 2.36% | 325,903 | 109.78M |
| 393 | LBRX | LB Pharmaceuticals Inc | 873.78M | 2.01% | 612,648 | - |
| 394 | PHAT | Phathom Pharmaceuticals, Inc. | 871.35M | 2.62% | 329,943 | 204.89M |
| 395 | TALK | Talkspace, Inc. | 869.39M | -0.38% | 3,439,669 | 238.37M |
| 396 | ABUS | Arbutus Biopharma Corporation | 869.17M | -2.65% | 2,467,707 | 191.45M |
| 397 | SLDB | Solid Biosciences Inc. | 866.36M | 6.02% | 1,754,740 | - |
| 398 | EVMN | Evommune, Inc. | 863.72M | 6.34% | 384,533 | 10.00M |
| 399 | GERN | Geron Corporation | 862.85M | 0.37% | 8,091,500 | 196.12M |
| 400 | DSGN | Design Therapeutics, Inc. | 855.97M | 0.04% | 394,721 | - |
| 401 | CERT | Certara, Inc. | 854.83M | 2.90% | 1,351,381 | 419.75M |
| 402 | AMPH | Amphastar Pharmaceuticals, Inc. | 848.35M | 4.96% | 368,078 | 720.53M |
| 403 | INMD | InMode Ltd. | 841.40M | 0.53% | 277,371 | 374.64M |
| 404 | QDEL | QuidelOrtho Corporation | 829.88M | -1.62% | 593,994 | 2.66B |
| 405 | VOR | Vor Biopharma Inc. | 819.29M | 1.20% | 731,767 | - |
| 406 | ESPR | Esperion Therapeutics, Inc. | 812.20M | -0.16% | 4,806,617 | 418.24M |
| 407 | AURA | Aura Biosciences, Inc. | 777.06M | 1.37% | 270,114 | - |
| 408 | BVS | Bioventus Inc. | 765.18M | 4.21% | 264,575 | 576.30M |
| 409 | ZVRA | Zevra Therapeutics, Inc. | 756.67M | 1.19% | 518,073 | 122.29M |
| 410 | HSTM | HealthStream, Inc. | 751.41M | 1.42% | 68,852 | 311.78M |
| 411 | OMER | Omeros Corporation | 749.08M | 0.19% | 521,421 | 9.89M |
| 412 | GMRS | GMR Solutions Inc. | 729.70M | -1.39% | 674,085 | 5.83B |
| 413 | ALLO | Allogene Therapeutics, Inc. | 719.65M | -0.71% | 3,069,181 | 22.00K |
| 414 | RLMD | Relmada Therapeutics, Inc. | 718.50M | -0.58% | 829,505 | - |
| 415 | NNNN | Anbio Biotechnology | 715.87M | -0.97% | 24,266 | 8.65M |
| 416 | OCS | Oculis Holding AG | 714.54M | 1.39% | 636,006 | 1.40M |
| 417 | IVA | Inventiva S.A. | 714.31M | 4.70% | 1,264,091 | 7.94M |
| 418 | SIBN | SI-BONE, Inc. | 709.59M | 1.14% | 144,831 | 206.22M |
| 419 | IMMX | Immix Biopharma, Inc. | 701.22M | 4.79% | 1,160,880 | - |
| 420 | CBLL | CeriBell, Inc. | 699.66M | 1.43% | 118,857 | 95.07M |
| 421 | CLYM | Climb Bio, Inc. | 695.14M | -0.33% | 519,315 | - |
| 422 | CTMX | CytomX Therapeutics, Inc. | 689.03M | 4.11% | 2,170,470 | 35.54M |
| 423 | TENX | Tenax Therapeutics, Inc. | 684.12M | 9.31% | 573,413 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 682.26M | 0.93% | 1,300,042 | 8.37M |
| 425 | SSII | SS Innovations International, Inc. | 680.45M | 1.19% | 29,881 | 48.47M |
| 426 | CRMD | CorMedix Inc. | 679.39M | -1.81% | 841,039 | 400.05M |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 662.15M | 0.16% | 143,599 | 299.77M |
| 428 | CADL | Candel Therapeutics, Inc. | 657.97M | -1.86% | 880,853 | - |
| 429 | SGP | SpyGlass Pharma, Inc. | 653.82M | 1.14% | 30,585 | - |
| 430 | CSTL | Castle Biosciences, Inc. | 651.49M | 1.32% | 151,062 | 339.92M |
| 431 | SLBT | SL Science Holding Limited | 631.95M | -13.50% | 191,422 | - |
| 432 | FDMT | 4D Molecular Therapeutics, Inc. | 629.93M | 15.64% | 1,201,376 | 88.24M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 628.76M | -1.64% | 216,717 | - |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 628.00M | -0.13% | 756,220 | 361.51M |
| 435 | AQST | Aquestive Therapeutics, Inc. | 626.62M | 5.83% | 2,076,508 | 50.27M |
| 436 | DRUG | Bright Minds Biosciences Inc. | 618.56M | 5.42% | 174,489 | - |
| 437 | AGMB | AgomAb Therapeutics NV | 612.18M | 4.99% | 43,109 | - |
| 438 | BBNX | Beta Bionics, Inc. | 611.39M | 0.15% | 239,785 | 110.24M |
| 439 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 606.41M | -3.81% | 311,627 | - |
| 440 | PRME | Prime Medicine, Inc. | 603.26M | -0.89% | 1,623,008 | 4.03M |
| 441 | TCMD | Tactile Systems Technology, Inc. | 601.35M | 1.68% | 110,619 | 343.52M |
| 442 | CBIO | Crescent Biopharma, Inc. | 588.82M | 0.85% | 109,699 | 11.88M |
| 443 | ALT | Altimmune, Inc. | 585.37M | 2.73% | 2,633,959 | 36.00K |
| 444 | BWAY | BrainsWay Ltd. | 582.36M | 0.28% | 48,221 | 56.22M |
| 445 | DNA | Ginkgo Bioworks Holdings, Inc. | 581.39M | -1.55% | 565,405 | 151.40M |
| 446 | TECX | Tectonic Therapeutic, Inc. | 577.11M | 0.81% | 53,875 | - |
| 447 | PHR | Phreesia, Inc. | 565.89M | 2.63% | 363,047 | 495.59M |
| 448 | GYRE | Gyre Therapeutics, Inc. | 560.11M | - | 33,369 | 117.05M |
| 449 | CLPT | ClearPoint Neuro, Inc. | 557.51M | 8.97% | 1,003,225 | 40.61M |
| 450 | MDXG | MiMedx Group, Inc. | 557.06M | 1.91% | 463,635 | 389.42M |
| 451 | TLRY | Tilray Brands, Inc. | 551.09M | 0.65% | 1,896,954 | 858.28M |
| 452 | MNPR | Monopar Therapeutics Inc. | 550.17M | 19.62% | 191,943 | - |
| 453 | NPCE | NeuroPace, Inc. | 543.11M | 3.64% | 99,409 | 99.53M |
| 454 | EVH | Evolent Health, Inc. | 535.97M | 6.36% | 1,010,032 | 1.89B |
| 455 | RGNX | REGENXBIO Inc. | 533.00M | 13.67% | 2,041,140 | 87.82M |
| 456 | CTKB | Cytek Biosciences, Inc. | 528.84M | 6.09% | 741,785 | 204.17M |
| 457 | XOMA | XOMA Royalty Corporation | 526.22M | -0.10% | 52,437 | 48.56M |
| 458 | ASMB | Assembly Biosciences, Inc. | 524.46M | 5.23% | 174,303 | 71.10M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 523.52M | 0.52% | 111,182 | - |
| 460 | CERS | Cerus Corporation | 522.96M | 0.38% | 1,877,285 | 216.56M |
| 461 | PROK | ProKidney Corp. | 522.56M | -4.95% | 526,739 | 889.00K |
| 462 | ANGO | AngioDynamics, Inc. | 521.65M | 1.01% | 134,317 | 313.73M |
| 463 | ARVN | Arvinas, Inc. | 520.69M | 4.26% | 481,577 | 89.40M |
| 464 | RZLT | Rezolute, Inc. | 519.20M | -3.50% | 1,039,877 | - |
| 465 | FLGT | Fulgent Genetics, Inc. | 518.38M | 2.31% | 116,331 | 320.35M |
| 466 | KYTX | Kyverna Therapeutics, Inc. | 513.11M | 1.69% | 299,964 | - |
| 467 | CTEV | Claritev Corporation | 509.39M | 5.06% | 70,761 | 978.76M |
| 468 | ACHV | Achieve Life Sciences, Inc. | 508.16M | -2.94% | 1,327,638 | - |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 470 | PRTA | Prothena Corporation plc | 503.64M | 5.14% | 210,752 | 57.94M |
| 471 | STRO | Sutro Biopharma, Inc. | 501.75M | -4.03% | 116,758 | 99.61M |
| 472 | NGNE | Neurogene Inc. | 501.16M | -1.66% | 66,484 | 925.00K |
| 473 | VALN | Valneva SE | 498.24M | 0.75% | 9,009 | 180.25M |
| 474 | TOI | The Oncology Institute, Inc. | 495.92M | -1.00% | 677,322 | 545.76M |
| 475 | CABA | Cabaletta Bio, Inc. | 491.61M | 0.17% | 1,679,149 | - |
| 476 | SRTA | Strata Critical Medical, Inc. | 478.92M | -3.74% | 730,098 | 228.58M |
| 477 | OCGN | Ocugen, Inc. | 477.32M | 9.30% | 6,679,872 | 4.47M |
| 478 | KIDS | OrthoPediatrics Corp. | 472.86M | 1.38% | 37,528 | 243.30M |
| 479 | CCCC | C4 Therapeutics, Inc. | 469.36M | 3.03% | 2,088,984 | 34.86M |
| 480 | ARTV | Artiva Biotherapeutics, Inc. | 467.90M | 2.88% | 233,423 | 251.00K |
| 481 | NVCT | Nuvectis Pharma, Inc. | 461.28M | 5.20% | 188,590 | - |
| 482 | MOBI | Mobia Medical, Inc. | 452.69M | -1.84% | 10,312 | 32.04M |
| 483 | BNTC | Benitec Biopharma Inc. | 451.24M | 6.79% | 57,624 | - |
| 484 | FBRX | Forte Biosciences, Inc. | 447.91M | 0.27% | 257,469 | - |
| 485 | CTNM | Contineum Therapeutics, Inc. | 447.70M | 3.06% | 223,862 | - |
| 486 | VREX | Varex Imaging Corporation | 442.96M | 1.06% | 199,402 | 857.50M |
| 487 | NRC | NRC Health | 442.40M | 0.72% | 45,712 | 138.64M |
| 488 | EOLS | Evolus, Inc. | 440.90M | 1.59% | 243,596 | 301.79M |
| 489 | VTVT | vTv Therapeutics Inc. | 439.67M | 4.45% | 32,751 | 36.84M |
| 490 | MYGN | Myriad Genetics, Inc. | 437.30M | 2.89% | 739,485 | 829.00M |
| 491 | SGMT | Sagimet Biosciences Inc. | 435.97M | -0.56% | 300,420 | - |
| 492 | EPRX | Eupraxia Pharmaceuticals Inc. | 432.67M | -3.01% | 613,159 | - |
| 493 | OVID | Ovid Therapeutics Inc. | 428.34M | 2.00% | 1,523,751 | 7.12M |
| 494 | WEAV | Weave Communications, Inc. | 427.28M | 4.07% | 642,704 | 248.72M |
| 495 | AUTL | Autolus Therapeutics plc | 426.81M | 7.63% | 1,101,956 | 92.62M |
| 496 | IPSC | Century Therapeutics, Inc. | 426.54M | 2.83% | 890,912 | 109.16M |
| 497 | INDP | Indaptus Therapeutics, Inc. | 423.53M | -0.93% | 161,697 | - |
| 498 | EDIT | Editas Medicine, Inc. | 422.79M | -1.61% | 1,392,868 | 38.69M |
| 499 | SOPH | SOPHiA GENETICS SA | 422.28M | -3.93% | 69,360 | 81.18M |
| 500 | PRLD | Prelude Therapeutics Incorporated | 420.51M | -1.85% | 177,485 | 16.72M |